Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:dateCreated |
1991-9-17
|
| pubmed:grant | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0883-5896
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
19-38
|
| pubmed:dateRevised |
2007-11-14
|
| pubmed:meshHeading |
pubmed-meshheading:1678363-Antineoplastic Agents,
pubmed-meshheading:1678363-Drug Resistance,
pubmed-meshheading:1678363-Humans,
pubmed-meshheading:1678363-Membrane Glycoproteins,
pubmed-meshheading:1678363-Neoplasm Proteins,
pubmed-meshheading:1678363-Neoplasms,
pubmed-meshheading:1678363-P-Glycoprotein,
pubmed-meshheading:1678363-Phenotype
|
| pubmed:year |
1991
|
| pubmed:articleTitle |
The multidrug resistance phenotype in human cancer.
|
| pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Review,
Research Support, Non-U.S. Gov't
|